Clin2
NCT06638970Possibly a fitNot yet recruiting

Stem cell treatment for hard-to-control seizures in adults

EpilepsyDrugs Resistant Epilepsy

Treatments studied

Part of Brain & nervous system clinical trials.

This trial is testing a new treatment made from human stem cells to see if it is safe and helpful for people whose seizures are not controlled by current medications. If you have drug-resistant epilepsy, this treatment might offer a new option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
54 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between the ages of 18 and 60.
  • You have a doctor-confirmed diagnosis of epilepsy.
  • You have had at least 6 seizures in the last year.
  • Your seizures are not controlled despite trying at least two different anti-seizure medicines for at least 12 months.
  • You have no other serious brain or psychiatric conditions, and you are generally in good health.
  • You have not had epilepsy surgery and you have no history of stroke.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07572812Not yet recruiting· Phase 1
Cell therapy for drug-resistant temporal lobe epilepsy

This trial tests a new cell-based treatment for people with epilepsy that has not improved with standard medications. The treatment aims to reduce seizures in patients with a specific type of epilepsy originating from one side of the brain.

Beijing, Beijing Municipality
NCT05518578Recruiting· Phase 2
Drug trial for hard-to-control focal epilepsy with brain scar

This Phase 2 trial tests SPN-817 in adults whose seizures are still not well controlled despite trying multiple seizure medicines. It targets people with a specific type of brain finding called focal cortical dysplasia and looks at safety/tolerability and seizure outcomes over several weeks.

Jacksonville, Florida
NCT06334952Recruiting
Personalized brain stimulation for hard-to-treat epilepsy

This study tests a personalized, non-invasive brain stimulation method called tDCS for people with drug-resistant epilepsy that starts in one part of the brain. It aims to reduce seizures in those who cannot have surgery or have not been helped by surgery.

Bordeaux
NCT06212609Recruiting
Personalized brain stimulation for kids with hard-to-control epilepsy

This trial tests a personalized brain stimulation method (transcranial electrical stimulation) to reduce seizures in children with hard-to-control partial epilepsy. It aims to find the best stimulation spot and settings for each patient by using advanced brain scans.

Amiens
NCT07520955Not yet recruiting
Magnetic brain stimulation for hard-to-treat seizures

This trial tests whether a type of magnetic brain stimulation can reduce seizures in people with epilepsy that isn't helped by current treatments. It uses a non-invasive method that may offer a new option for controlling seizures.

Madison, Wisconsin
NCT07790224Not yet recruiting
Brain stimulation study for epilepsy monitoring

This trial tests a non-invasive brain stimulation technique during routine epilepsy monitoring to see if it can help reduce seizures. It may offer a new way to manage epilepsy without surgery.

Beijing, Beijing Municipality

Hear when a new Epilepsy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.